Clinical Trial: Symplicity China Study

U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07081243) titled 'Symplicity China Study' on July 03.

Brief Summary: The Symplicity China study will evaluate the real-world long-term safety, efficacy, and durability of the Symplicity Spyral system in a population of approximately 500 renal denervation treated subjects with up to 36 months of follow up.

Study Start Date: July 30

Study Type: OBSERVATIONAL

Condition: Resistant Hypertension

Intervention: DEVICE: Symplicity Spyral Renal Denervation System

Symplicity Renal Denervation

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Medtronic Vascular

Disclaimer: Curated by HT Syndication....